Borders Should No Longer Be Barriers
In Clinical Trials

EU-X-CT Public Stakeholder Conference: Final Recommendations Launch!

Join us live in Brussels onsite or online on 24 June 2025

Cross-Border Access to Clinical Trials

For many patients with life-threatening or rare diseases, participating in a clinical trial abroad is sometimes the only option—but without an EU-wide legal framework or guidance, barriers remain high, and access out of reach.

EU-X-CT is a multi-stakeholder initiative aimed at systematically collecting information on the barriers to cross-border participation in clinical trials within Europe and developing recommendations for enabling better access.

The initiative is a concerted effort by volunteers from patient organisations, academics, research networks, industry, and not-for-profit organisations, led by EFGCP and EFPIA.

Watch the video to learn more: Click Here

EU-X-CT to Launch Final Recommendations at its upcoming Public Stakeholder Conference 2025

The EU-X-CT initiative is pleased to announce it will be launching final practical recommendations at its Public Stakeholder Conference on 24 June 2025.

Taking place live in Brussels, the Initiative will showcase the information and insights collected over the past 2 years from multiple stakeholders on regulatory, ethical, social security and organisational conditions as well as experiences, and best practices for cross-border access to clinical trials across Europe.

The hybrid event will convene stakeholders and policy makers and explore an actionable pathway, making cross-border access to clinical trials a reality for all.

Brussels
Hybrid
24/06/2025
1 Day

New Tools Available

News

EU-X-CT Country Analysis: Preliminary Version
The preliminary version of the Country Analysis is available and covers an initial group of EU countries, more to come! 2025-03-03
EU-X-CT Recommendations: Public Consultation
The EU-X-CT Recommendations are available for Public Consultation for 5 weeks - Submit your review now! 2025-02-03
EPF Joins EU-X-CT Cross-Border Clinical Trials Initiative as a Member
EPF Joins EU-X-CT 2024-10-31
Clarifying the cross-border trial access in Europe
Interview with our CRO partner published by Clinical Trials Arena 2024-05-30
The EU-X-CT Public Stakeholders Forum
EU-X-CT Public Stakeholders Forum Featured in PinkSheet Article 2024-05-06

Our Objectives

Raise Awareness

To connect with existing and new initiatives to raise awareness about current issues that hinder access to clinical trials beyond a patient's home country

Gather Information

To collect comprehensive information on barriers to cross-border clinical trial access covering legal, regulatory, financial, and practical aspects

Publish Recommendations

To develop and publish recommendations to enable better access to cross-border clinical trials

Roadmap

Our Stakeholders

Patient Representation

  • Patients and Carers
  • Patient Advocates
  • Patient organisations

Legal and Regulatory

  • EU and national policymakers
  • Regulators
  • Ethics committees

Insurance

  • Insurance companies
  • Payers

Clinical and Academic

  • Investigators and study groups
  • Pharmaceutical associations
  • Industry and academic sponsors
  • European Research Networks
  • Medical and professional societies

Our Leadership


With the Support of

Gold

Silver

Bronze